Next 10 |
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout PR Newswire Event will take place on Wednesday, June 26, 2024 in New York CARMIEL, Israel , J...
Protalix BioTherapeutics to Present at the 2024 BIO International Convention PR Newswire Corporate presentation scheduled for Monday, June 3, 2024 at 2:30 P.M. PDT CARMIEL, Israel , May 29, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc....
2024-05-10 11:54:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Protalix BioTherapeutics (NYSEMKT: PLX ) just reported results for the first quarter of 2024. Protalix BioTherapeutics reported earnings per share of -6 cents. This was be...
2024-05-10 11:13:09 ET Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Conference Call May 10, 2024 8:30 AM ET Company Participants Mike Moyer - Managing Director, LifeSci Advisors Dror Bashan - President and CEO Eyal Rubin - SVP and CFO Conference Ca...
2024-05-10 06:54:34 ET More on Protalix BioTherapeutics Protalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earnings data for Protalix BioTherapeutics Financial infor...
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results PR Newswire Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel , May 10, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE Ameri...
2024-05-09 12:27:48 ET More on Protalix BioTherapeutics Protalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earnings data for Protalix BioTherapeutics Financial infor...
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024 PR Newswire Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , May 3, 2024 /PRNewswire/ -- Protalix BioTherapeutics...
2024-03-14 13:02:10 ET Protalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Conference Call March 14, 2024 08:30 ET Company Participants Lauren Merrick - Investor Relations Dror Bashan - President and Chief Executive Officer Eyal Rubin - Senior Vice President an...
2024-03-14 06:51:52 ET More on Protalix BioTherapeutics Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earnings data for Protalix BioTherapeutics Financial information for Protalix BioTherapeutics Read the full article on Seeking...
News, Short Squeeze, Breakout and More Instantly...
Protalix BioTherapeutics Inc. Company Name:
PLX Stock Symbol:
NYSE Market:
Protalix BioTherapeutics Inc. Website:
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout PR Newswire Event will take place on Wednesday, June 26, 2024 in New York CARMIEL, Israel , J...
Protalix BioTherapeutics to Present at the 2024 BIO International Convention PR Newswire Corporate presentation scheduled for Monday, June 3, 2024 at 2:30 P.M. PDT CARMIEL, Israel , May 29, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc....